With disruptive political and legislative change on the horizon at home and abroad, it has never been more important for European biopharma patent professionals to have a crystal-clear understanding of the changes shaping IP protection and value creation.
IAM’s third annual Pharma & Biotech IP event will provide cutting-edge legal and strategic insights to help practitioners safeguard and exploit their crucial life sciences assets.
We are pleased to once again sponsor The Rushlight Show 2019. Now in its 10th year this event is expected to attract over 500 cleantech CEOs and entrepreneurs, investors, advisers, corporate customers and others involved in the sector. It includes: